EnVVeno Medical Net Worth
EnVVeno Medical Net Worth Breakdown | NVNO |
EnVVeno Medical Net Worth Analysis
EnVVeno Medical's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including EnVVeno Medical's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of EnVVeno Medical's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform EnVVeno Medical's net worth analysis. One common approach is to calculate EnVVeno Medical's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares EnVVeno Medical's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing EnVVeno Medical's net worth. This approach calculates the present value of EnVVeno Medical's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of EnVVeno Medical's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate EnVVeno Medical's net worth. This involves comparing EnVVeno Medical's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into EnVVeno Medical's net worth relative to its peers.
Enterprise Value |
|
To determine if EnVVeno Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding EnVVeno Medical's net worth research are outlined below:
| enVVeno Medical Corp had very high historical volatility over the last 90 days | |
| Net Loss for the year was (21.82 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| enVVeno Medical Corp currently holds about 37.48 M in cash with (16.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from thelincolnianonline.com: enVVeno Medical Corporation Short Interest Update |
EnVVeno Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in enVVeno Medical Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to EnVVeno Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 25th of January 2024 Upcoming Quarterly Report | View | |
| 6th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 25th of January 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know EnVVeno Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as EnVVeno Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading enVVeno Medical Corp backward and forwards among themselves. EnVVeno Medical's institutional investor refers to the entity that pools money to purchase EnVVeno Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Northern Trust Corp | 2024-12-31 | 56.7 K | Hohimer Wealth Management, Llc | 2024-12-31 | 51.3 K | Marshall Wace Asset Management Ltd | 2024-12-31 | 48.8 K | Squarepoint Ops Llc | 2024-12-31 | 47.9 K | State Street Corp | 2024-12-31 | 40.8 K | Blackrock Inc | 2024-12-31 | 40.6 K | Quadrature Capital Llp | 2024-12-31 | 39.2 K | Fermata Advisors, Llc | 2024-12-31 | 35.7 K | Virtu Financial Llc | 2024-12-31 | 28.5 K | Kingdon Capital Management Llc | 2024-12-31 | 859.3 K | Nantahala Capital Management, Llc | 2024-12-31 | 596.9 K |
Follow EnVVeno Medical's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 50.85 M.Market Cap |
|
Project EnVVeno Medical's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.49) | (0.51) | |
| Return On Capital Employed | (0.56) | (0.53) | |
| Return On Assets | (0.49) | (0.51) | |
| Return On Equity | (0.52) | (0.54) |
When accessing EnVVeno Medical's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures EnVVeno Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of EnVVeno Medical's profitability and make more informed investment decisions.
Evaluate EnVVeno Medical's management efficiency
enVVeno Medical Corp has return on total asset (ROA) of (0.3182) % which means that it has lost $0.3182 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4939) %, meaning that it created substantial loss on money invested by shareholders. EnVVeno Medical's management efficiency ratios could be used to measure how well EnVVeno Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of the 21st of March 2025, Return On Tangible Assets is likely to drop to -0.51. In addition to that, Return On Capital Employed is likely to grow to -0.53. At this time, EnVVeno Medical's Non Current Assets Total are very stable compared to the past year. As of the 21st of March 2025, Intangible Assets is likely to grow to about 781.6 K, while Total Assets are likely to drop about 23.9 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 2.46 | 2.58 | |
| Tangible Book Value Per Share | 2.46 | 2.58 | |
| Enterprise Value Over EBITDA | (2.14) | (2.25) | |
| Price Book Value Ratio | 1.23 | 1.29 | |
| Enterprise Value Multiple | (2.14) | (2.25) | |
| Price Fair Value | 1.23 | 1.29 | |
| Enterprise Value | 54.9 M | 57.7 M |
Leadership effectiveness at enVVeno Medical Corp is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific EnVVeno Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on EnVVeno Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases EnVVeno Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
EnVVeno Medical Corporate Filings
| 12th of March 2025 Other Reports | ViewVerify | |
10K | 28th of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
F4 | 3rd of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 19th of November 2024 Other Reports | ViewVerify |
EnVVeno Medical Earnings per Share Projection vs Actual
EnVVeno Medical Corporate Management
| Andrew Cormack | Chief Officer | Profile | |
| Craig Glynn | Treasurer CFO | Profile | |
| Benedict MD | Chief States | Profile | |
| Sandy Prietto | Vice Marketing | Profile | |
| Robert Berman | CEO Director | Profile | |
| Marc MD | Senior Officer | Profile | |
| Hamed Alavi | Senior Officer | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnVVeno Medical. If investors know EnVVeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnVVeno Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of enVVeno Medical Corp is measured differently than its book value, which is the value of EnVVeno that is recorded on the company's balance sheet. Investors also form their own opinion of EnVVeno Medical's value that differs from its market value or its book value, called intrinsic value, which is EnVVeno Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnVVeno Medical's market value can be influenced by many factors that don't directly affect EnVVeno Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EnVVeno Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if EnVVeno Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnVVeno Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.